Zero Longevity Science is a technology company.
Zero Longevity Science has raised $12.0M across 3 funding rounds.
Zero Longevity Science has raised $12.0M in total across 3 funding rounds.
Zero Longevity Science has raised $12.0M in total across 3 funding rounds.
Zero Longevity Science's investors include AME Cloud Ventures, Hardware Club, Redpoint eventures, Trinity Ventures.
Zero Longevity Science is a San Francisco-based health tech company founded in 2018 that develops the Zero app, a top-rated mobile tool for tracking intermittent fasting and building sustainable health habits.[1][2][4] The app serves individuals seeking weight loss, metabolic health improvement, and longevity by offering personalized guidance, real-time progress tracking, app integrations, and science-backed insights from a Scientific Advisory Board, addressing issues like obesity (affecting 73% of U.S. adults) and metabolic unwellness (88%).[1][4] Users report significant outcomes, including millions of pounds lost collectively, reversed conditions like diabetes, and enhanced energy, with strong growth evidenced by app store praise for motivation tools, education, and results like 50-pound losses.[4]
Zero Longevity Science emerged in 2018 amid rising interest in intermittent fasting for metabolic health, headquartered at 1459 18th Street in San Francisco.[1][2] Key leaders include CEO Luke Maser, with operational and health expertise, and Conrad (likely President or co-leader), a consumer product and engineering veteran whose passion for Zero intensified during the pandemic; he uses it personally to scale the mission of unlocking metabolic health.[1] The idea stemmed from scientific research on fasting's benefits for weight management and longevity, evolving into a user-centered app during a time when diet failures were rampant, gaining early traction through pandemic-driven health awareness and user transformations like rapid blood sugar normalization.[1][4]
Zero rides the longevity and metabolic health wave, fueled by post-pandemic demand for non-pharmaceutical solutions to obesity and chronic diseases, where 73-88% of adults face metabolic issues.[1] Timing aligns with booming digital health adoption—intermittent fasting apps tap into AI-personalized wellness trends, competing with platforms like DNAnexus or Huma but differentiating via consumer fasting focus amid a $4T+ global health market.[1][3][4] Market forces like wearable integrations and remote monitoring favor Zero, influencing the ecosystem by normalizing science-driven habits, inspiring similar apps, and contributing to precision health shifts toward prevention over treatment.[1][2]
Zero is poised to expand as personalized longevity tech integrates deeper with wearables, AI coaching, and telehealth, potentially adding features like advanced biomarker tracking or enterprise wellness partnerships.[1][4] Trends like rising metabolic disorder awareness and habit-formation AI will propel growth, evolving its influence from individual tracker to ecosystem leader in preventive health. With proven momentum in user transformations, Zero could scale toward broader longevity tools, sustaining its edge in a dieting-fatigued world.[4]
Zero Longevity Science has raised $12.0M across 3 funding rounds. Most recently, it raised $8.0M Series A in May 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2020 | $8.0M Series A | AME Cloud Ventures, Hardware Club, Redpoint eventures, Trinity Ventures | |
| Aug 1, 2019 | $3.0M Seed | AME Cloud Ventures, Hardware Club, Redpoint eventures, Trinity Ventures | |
| Sep 1, 2018 | $1.0M Seed | AME Cloud Ventures, Hardware Club, Redpoint eventures, Trinity Ventures |